Anzeige
Mehr »
Freitag, 10.04.2026 - Börsentäglich über 12.000 News
Research Capital bestätigt $3,00 Kursziel - FUTR zündet die nächste Stufe: Vom Fintech zur globalen Finanzplattform
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
18.03.First MHRA/NICE aligned guidance due in June
18.03.Hope rises for vaccine against hookworm parasite
18.03.US court says pharma giants must face False Claims suit
17.03.Meningitis outbreak in UK prompts call to widen vaccination
17.03.Alto raises $120m for resistant depression programme
17.03.BioMarin halts Voxzogo trials due to safety signal
17.03.Roche accelerates AI adoption with NVIDIA deal
17.03.US judge rules Kennedy's vaccine changes 'unlawful'
16.03.AZ piles pressure on MSD et al in gastric cancer
16.03.Denying prostate cancer screening 'no longer rational'
16.03.Data builds behind Bayer's Kerendia in kidney disease
16.03.J&J says Inlexzo follow-up 'promising' in bladder cancer
16.03.GSK's RSV shot cleared in US for all adults
13.03.Regenxbio, Solid report data with Duchenne gene therapies
13.03.NHS hospitals 'should resist Palantir software rollout'
13.03.Immutep investors spooked by LAG-3 failure in lung cancer
13.03.Poll finds Americans cutting back elsewhere to fund health
12.03.Iran hackers claim cyberattack at US medtech firm
12.03.Ipsen appoints Michelle Werner as North America head
12.03.Evotec slashes staff as turnaround plan gathers pace
12.03.Eisai joins with Pokémon for sleep awareness drive
12.03.NVIDIA sinks $2bn into AI cloud provider Nebius
11.03.Novo rapped by FDA for not reporting drug adverse effects
11.03.NHS cleared to use Astellas' non-hormonal menopause drug
11.03.Vertex preps FDA filing for IgAN drug after phase 3 readout